Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis.

MLA

Sun, Hao, et al. “Survival Benefit of Perioperative Locoregional Adjuvant Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Bayesian Network Meta-Analysis.” Critical Reviews in Oncology/Hematology, vol. 189, Sept. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2023.104083.

APA

Sun, H., Ma, B., Sun, N., Bai, H., Li, X., & Zhang, C. (2023). Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis. Critical Reviews in Oncology/Hematology, 189, N.PAG. https://doi.org/10.1016/j.critrevonc.2023.104083

Chicago

Sun, Hao, Bing Ma, Ning Sun, Han Bai, Xuejian Li, and Chengshuo Zhang. 2023. “Survival Benefit of Perioperative Locoregional Adjuvant Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Bayesian Network Meta-Analysis.” Critical Reviews in Oncology/Hematology 189 (September): N.PAG. doi:10.1016/j.critrevonc.2023.104083.